XML 131 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Nature of Operations and Basis of Presentation (Tables)
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Schedule of Condensed Financial Statements

The consolidated financial statements include all accounts of the entities as of the reporting period ending dates and for the reporting periods as follows:

 

Name of consolidated subsidiary  State or other jurisdiction of incorporation or organization  Date of incorporation or formation  Attributable interest as of
June 30, 2023		   Attributable
interest as of
December 31,
2022		 
               
Global BioMedical, Inc.  Nevada  April 18, 2017   90.9%   90.9%
Global BioLife, Inc.  Nevada  April 14, 2017   81.8%   81.8%
BioLife Sugar, Inc  Nevada  April 23, 2018   90.9%   90.9%
Happy Sugar Inc  Nevada  August 17, 2018   81.8%   81.8%
Sweet Sense Inc.  Nevada  April 30, 2018   95.5%   95.5%
Global Sugar Solutions Inc.  Nevada  November 7, 2019   100%   100%

 

The consolidated financial statements include all accounts of the entities as of the reporting period ending dates and for the reporting periods as follows:

 

Name of consolidated subsidiary  State or other jurisdiction of incorporation or organization  Date of incorporation or formation  Attributable interest as of
December 31,
2022		   Attributable
interest as of
December 31,
2021		 
               
Global BioMedical, Inc.  Nevada  April 18, 2017   90.9%   90.9%
Global BioLife, Inc.  Nevada  April 14, 2017   81.8%   63.6%
BioLife Sugar, Inc  Nevada  April 23, 2018   90.9%   63.6%
Happy Sugar Inc  Nevada  August 17, 2018   81.8%   63.6%
Sweet Sense Inc.  Nevada  April 30, 2018   95.5%   81.8%
Global Sugar Solutions Inc.  Nevada  November 7, 2019   100%   80%